Variable clinical course has been reported with the acquisition of Burkhold
eria cepacio in patients who have cystic fibrosis (CF). We hypothesized tha
t the perceived worsening with B. cepocia may reflect the underlying severi
ty of pulmonary disease at the time of acquisition. To test this hypothesis
, we matched CF patients colonized with B. cepacia with CF patients not col
onized with the organism. Two-year pre- and postacquisition data and long-t
erm data were compared. Patients were matched for gender, age (+/- 1 yr), h
eight (+/- 5 cm), weight (+/- 8 kg), percent predicted forced expiratory vo
lume in one second (% pred FEV1) (+/- 10%), and pancreatic sufficiency stat
us. Differences in rates of change pre- and postacquisition for FEV1, FVC,w
eight, and frequency of intravenous courses were compared within pairs with
the Wilcoxon signed rank test. Two-year and long-term survival was compare
d within pairs with the McNemar test. No significant differences were obser
ved in mean annual rates of change in weight (0.33 and -0.28 kg/yr), % pred
FEV1 (-0.36 and -1.74%/yr), and percent predicted forced vital capacity (%
pred FVC) (-3.80 and -2.32%/yr) between B. cepacio and control pairs in 2-
yr and long-term postacquisition interval, respectively. Similar rates of c
hange were noted for pre- to postacquisition intervals within pairs for wei
ght (0.17 kg/yr), % pred FEV1 (-0.16%/yr), % pred FVC (5.02 %/yr). There wa
s a significantly higher rate of intravenous antibiotic courses in B. cepoc
ia cases in the 2-yr and long-term postacquisition interval. Higher mortali
ty was observed in the B. cepacia cases in the long term (p < 0.05). We con
clude that colonization with B. cepacia does not necessarily adversely affe
ct pulmonary status, but is associated with reduced long term survival. Whe
reas previous associations may be attributed to a propensity to colonize th
ose who had more advanced disease, specific strain types of B. cepacio may
have enhanced pathogenicity.